BRACAnalysis CDX
BRACAnalysis CDx® is an FDA-approved test used to identify patients with germline BRCA1/2 mutations who may be eligible for certain targeted therapies.
mutation CreateOrder {
createOrder(
order: {
products: { product: BRACANALYSIS, cdx: true }
patient: {
firstName: "Test10"
lastName: "Myriad"
dob: "1965-01-01"
genderCode: FEMALE
address: {
street: "233 Sprint St"
city: "New York"
stateCode: NY
postalCode: "10013"
}
mobilePhoneNumber: "222-222-2222"
}
clinical: {
cancerRisk: { riskAnalysisOption: EXCLUDE_TC_AND_RISKSCORE }
familyCancerHistory: [
{
relationshipTypeCode: FIRST_COUSIN
cancerHistory: [
{ diagnosisAge: { age: 30 }, cancerSiteCode: BRAIN_TUMOR }
]
}
]
personalCancerHistory: [
{ pancreatic: { diagnosisAge: 25, currentlyBeingTreated: false } }
]
}
requisitionNumber: "636339851"
specimens: [
{
germline: {
collectionDate: "2024-04-15"
hospitalizationCode: NON_HOSPITAL_PATIENT
}
}
]
providerAccounts: [
{
role: ORDERING
provider: {
firstName: "Karla"
lastName: "Bowles"
identifiers: [{ use: OFFICIAL, type: NPI, value: "1750369955" }]
}
location: {
address: {
street: "320 Wakara Way"
city: "Salt Lake City"
stateCode: UT
}
}
organization: {
identifiers: [
{ use: OFFICIAL, type: XX, value: "FAKE_MYRIAD_ORGANIZATION_ID" }
]
}
}
]
}
) {
id
}
}